Wade: are you referring to GERN or CVS ? GERN is now $1.88 down nearly 50% from mid June .... CVS is up around 7% from the June lows and pays a decent dividend.
CVS is a value play at this price and seems to have bottomed, but I see the upside as limited, perhaps $80 is fair value. At least one gets a dividend.
GERN was a very poor choice in the biotech sector. GERN will be lucky to get to breakeven in 2025. It's a money losing dilution machine and no wonder that it's performing so poorly.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.